Fig. 7
From: FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
Cell cycle analysis of each of the three groups of cells treated with different concentrations of cisplatin (%, ±s). *,P < 0.05,compared with other two groups treated with cisplatin (0 μg/ml);▲P < 0.05,compared with other two groups treated with cisplatin (1.8 μg/ml);#,P < 0.05,compared with other two groups treated with cisplatin (3.6 μg/ml);⃟,P < 0.05,compared with other two groups treated with cisplatin (7.2 μg/ml)